-
Rwanda, Merck and QIAGEN Launch Africa's First Comprehensive Cervical Cancer Prevention Program Incorporating Both HPV Vaccination and HPV Testing
Monday, April 25, 2011 - 8:35am | 117The Government of Rwanda, together with QIAGEN N.V. (NASDAQ: QGEN) and Merck (NYSE: MRK) today announced the launch, in Kigali, Rwanda, of a comprehensive national cervical cancer prevention program that includes vaccination with GARDASIL for appropriate girls 12 to 15 years of age and modern...
-
FDA Grants Orphan Drug Designation For Nektar's Investigational Drug (NKTR)
Thursday, April 21, 2011 - 8:04am | 80Nektar Therapeutics (Nasdaq: NKTR) today announced that the company's oncology drug candidate, NKTR-102, has been granted orphan drug status for the treatment of women with ovarian cancer by the U.S. Food and Drug Administration. "This designation is an important step in the overall development...
-
Nektar Therapeutics Receives FDA Orphan Status Approval -Rumor (NKTR)
Wednesday, April 20, 2011 - 3:10pm | 78Rumors Circulate That Nektar Therapeutics (NASDAQ: NKTR) Receives FDA Orphan Status Approval. http://www.accessdata.fda.gov/scripts/opdlisting/oopd/OOPD_Results_2.cfm?Index_Number=338011 This article may include mentions of rumors, chatter, or unconfirmed information. Readers should beware that...
-
Nektar Therapeutics Receives FDA Orphan Status Approval -Rumor (NKTR)
Wednesday, April 20, 2011 - 3:10pm | 78Rumors Circulate That Nektar Therapeutics (NASDAQ: NKTR) Receives FDA Orphan Status Approval. http://www.accessdata.fda.gov/scripts/opdlisting/oopd/OOPD_Results_2.cfm?Index_Number=338011 This article may include mentions of rumors, chatter, or unconfirmed information. Readers should beware that...
-
March Architecture Index Holds Steady
Wednesday, April 20, 2011 - 10:51am | 394From the American Institute of Architects: "The March 2011 Architecture Billings Index (ABI) remains virtually unchanged and right at, or slightly above, the break-even level. As a leading economic indicator of construction activity, the ABI reflects the approximate nine to twelve month lag time...
-
Top 4 Small-Cap Stocks In The Medical Laboratories & Research Industry With The Highest EPS Estimates (ICLR, PRXL, BRLI, MTOX)
Wednesday, April 20, 2011 - 12:14am | 149Below are the top small-cap medical laboratories & research stocks on the NYSE and the NASDAQ in terms of earnings estimate for the next year. The earnings estimate for ICON plc (NASDAQ: ICLR) for the next year ending December, 2012 is $1.54 per share. ICLR's trailing-twelve-month ROE is 14.02...
-
Morning Market Losers (FFHL, HGSH, PBIO, ABMD)
Thursday, April 14, 2011 - 10:00am | 114Fuwei Films (Holdings) Co Ltd (NASDAQ: FFHL) fell 19.08% to $3.69 at 10:00 am. FFHL shares have jumped 303.54% over the past 52 weeks, while the S&P 500 index has gained 8.57% in the same period. China HGS Real Estate Inc (NASDAQ: HGSH) shares dipped 14.62% to $2.22. HGSH's trailing-twelve-...
-
Deutsche Bank Maintains Buy Rating On CVD, ICLR
Thursday, April 14, 2011 - 8:10am | 64Deutsche Bank is retaining its Buy rating on Covance Inc. (NYSE: CVD), “who is best positioned to capitalize on strategic deal momentum,” and ICON (NASDAQ: ICLR), “whose valuation discount to peers could unwind given potential operating margin expansion post recent restructuring.” Covance closed...
-
Accelr8 Announces Option Exercise to Continue BACcel Technology Evaluation, and Additional Presentations at Major Medical Meetings
Thursday, April 14, 2011 - 7:47am | 90Accelr8 Technology Corporation (NYSE: AXK) announced that it received notification by its industry collaborator of exercise of an option to continue its technology evaluation program for Accelr8's BACcel rapid diagnostic system. As previously announced, the two companies have an agreement that...
-
MEDTOX Scientific Reports Q1 EPS of $0.09
Thursday, April 14, 2011 - 7:05am | 56MEDTOX Scientific Inc (NASDAQ: MTOX) reported its Q1 EPS at $0.09, versus the consensus of $0.08. MTOX reported its Q1 revenue at $25.7 million, versus the consensus of $24.5 million. MTOX shares gained 0.19% to close at $15.64 yesterday. Read more from Benzinga's Company news.
-
Earnings Scheduled For April 14 (HAS, GOOG, MTOX, FCS, CBK, CHKP, SVU, PRSP, MMSI)
Thursday, April 14, 2011 - 1:10am | 247Hasbro Inc (NASDAQ: HAS) is estimated to post its Q1 earnings at $0.17 per share on revenue of $661.02 million. Google Inc (NASDAQ: GOOG) is projected to report its Q1 EPS at $8.13 on revenue of $6.32 billion. Medtox Scientific Inc (NASDAQ: MTOX) is expected to report its Q1 EPS at $0.08 on...
-
Pressure BioSciences Receives $825,720 as the First Tranche of a $6.0 Million Private Placement
Wednesday, April 13, 2011 - 9:22am | 142Pressure BioSciences (NASDAQ: PBIO) today announced that it has received gross proceeds of $825,720 from the sale of 55,048 units to 10 accredited investors, including the Company's CEO and President, in the first tranche of the Company's $6.0 million Series C private placement. Each unit was...
-
Top Percentage Gainers And Losers As Of 2 p.m. 4/12/2011 (CYH, THC, IDIX, BAC, SKH, JPM, BIO, REDF, DEER, THC, CYTX, CCRT, WMS, EXTR, LFT, SB, DRRX, BRNC, MCRL)
Tuesday, April 12, 2011 - 2:09pm | 558Best 1) Community Health Systems (NYSE: CYH): Shares are surging 13.09% to $2.32 as skepticism grows about Tenet Healthcare's (NYSE: THC) lawsuit against the company. The stock took a huge hit in yesterday's session, trading down as low as $22.32 after Tenet's lawsuit alleging illegal admission...
-
Medivation Hits 52-Week High (MDVN)
Tuesday, April 12, 2011 - 1:40pm | 32Medivation (NASDAQ: MDVN) has hit a 52-week high in today's trading. At last check the year-to-date performance of Medivation has been a gain of 39.2%.
-
Options Brief: Exelixis, Inc. (EXEL)
Tuesday, April 12, 2011 - 10:54am | 86Shares of Exelixis, Inc. (NASDAQ: EXEL) are higher on the session by 6.70%, trading at $11.79. Overall call volume is now running at 5.88x the daily average, with 59% of all calls traded being purchases on the offer. 1,724 contracts have traded on the session so far. Exelixis, Inc. is focused on...